Annabidiol Corp.
ACBD · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.80 | 0.00 | 18.59 | -1.66 |
| FCF Yield | 0.00% | -0.48% | -0.08% | 0.01% |
| EV / EBITDA | -796.82 | -1,393.74 | -2,206.92 | 407.76 |
| Quality | ||||
| ROIC | 116.85% | 5.54% | 5.49% | -27.71% |
| Gross Margin | 0.00% | 100.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | 6.65 | 1.85 | 0.05 | 0.86 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -48.91% | -71.15% | – |
| Free Cash Flow Growth | 0.00% | -165.74% | -820.41% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.12 | 0.99 | 0.08 | -0.41 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |